Abstract
A team from Crucell and Scripps has identified a trio of human mAbs that protect mice from influenza, including one that hits both A and B strains of the virus. Parent company Johnson & Johnson plans to develop the antibodies and in the long run could use the antibody against A and B strains as a guide for a universal flu vaccine.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
